Diabetes Technology and Therapeutics Template
Get your Diabetes Technology and Therapeutics paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.2
How to Use the Diabetes Technology and Therapeutics Template | A Step-by-Step Guide
Authored by Sumalatha Gangadhar | Published on 10 August, 2026
Submitting to Diabetes Technology and Therapeutics goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Diabetes Technology and Therapeutics guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
What is the Diabetes Technology and Therapeutics Template?
It is a manuscript shell aligned to Diabetes Technology and Therapeutics. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Diabetes Technology and Therapeutics journal page before you draft.
What's actually in a Diabetes Technology Ther submission:
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Diabetes Technology and Therapeutics guide for authors lists, and cite figures and tables in order.
What separates a clean submission from one that gets kicked back:
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Diabetes Technology and Therapeutics guide for authors before you submit.
What does this Diabetes Technology and Therapeutics Template include?
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through ScholarOne (Manuscript Central).
Steps to Use This Template with SciSpace Agent
- Click Start Writing on this page. The SciSpace Agent prompt screen opens with the template loaded.
- Use the loaded template, or upload a version your group already uses for Diabetes Technology Ther.
- Edit the prompt with your topic and article type, and note any requirement from the Diabetes Technology and Therapeutics guide for authors.
- Run the prompt. The agent drafts into the correct structure and reference style.
- Use View Outputs to verify required statements and formatting are present.
- Export and submit through ScholarOne (Manuscript Central).
Diabetes Technology and Therapeutics Template Structure at a Glance
| Element | Diabetes Technology Ther requirement |
|---|---|
| Abstract | Original Articles: Structured abstract of no more than 300 words. Review Articles: Unstructured abstract of no more than 300 words. Brief Reports: Unstructured abstract of no more than 150 words. Commentaries and Guest Editorials: No abstract. Clinical Trials: The trial registry name and URL, and registration number must be included at the end of the abstract |
| Main text | Original Articles: 5,000-word limit. Review Articles: 6,000-word limit. Brief Reports: 2,000-word limit. Commentaries: 1,000-word limit. Guest Editorials: 1,000-word limit. Letters to the Editor: 500-word limit. Observational Letters: 750-word limit. Note: Word limits do NOT pertain to the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, or references |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | Minimum of 4 keywords required. Keywords should be as specific as possible to the research topic |
| References | Sage Vancouver reference style. Every in-text citation must have a corresponding citation in the reference list and vice versa. Citations to preprints are discouraged but must be updated if a peer-reviewed version becomes available. For Letters to the Editor and Observational Letters, citations should not exceed five (5) |
| Peer review | The official author instructions page contains conflicting information: the summary states 'Single-anonymized' but the detailed Peer Review Policy section states 'The journal adheres to a rigorous double-anonymized reviewing policy in which the identity of both the reviewer and author are always concealed from both parties.' Two independent reviews are required for a manuscript to reach a Revise or Accept decision |
| Submission | mc.manuscriptcentral.com/diabetestechnology |
Quick Tips for Using the Diabetes Technology and Therapeutics Template
Read the Diabetes Technology and Therapeutics guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Diabetes Technology and Therapeutics in under a page.
Best Practices
Skim two or three recent Diabetes Technology Ther papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Diabetes Technology and Therapeutics journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Before You Submit: Final Check
Do one focused pass against the Diabetes Technology and Therapeutics guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through ScholarOne (Manuscript Central).
